Pharmahungary Group


Pharmahungary Group is a research and development company specializing in innovative preclinical and clinical R&D services, as well as developing in-house projects for diagnostics and therapeutics. They focus on cardiovascular, metabolic, renal, inflammation, and neuropathy diseases, providing strong scientific and regulatory support. The company is ISO 9001:2015 certified and actively participates in international conferences and collaborations to advance medical research and development.

Industries

biotechnology
health-diagnostics
pharmaceutical

Nr. of Employees

small (1-50)

Pharmahungary Group


Products

Cytoprotective microRNA therapeutic program

In-house R&D program focused on identification and development of cytoprotective microRNA targets for therapeutic application.

Biomarker diagnostic system for myocardial ischemia prognosis

In-house diagnostic R&D project creating a biomarker-based system to assess prognosis after acute myocardial ischemia/reperfusion injury.

Chromatography platform for exosome isolation

Modular and scalable chromatography-based platform for high-quality exosome isolation intended for research and downstream applications.

Bioinformatics tools (target prediction, adverse event prediction)

Computational tools for microRNA target prediction and for prediction/detection of previously unknown adverse events and drug interactions.

AI-assisted infarct quantification system

Automated image-analysis product for identification and quantification of infarct regions in stained heart tissue sections using artificial intelligence.


Services

Preclinical R&D services (CRO)

End-to-end preclinical services from cellular assays to large animal disease models, focused on cardiovascular, metabolic, renal, inflammation and neuropathy indications.

Clinical R&D services (CRO)

Full CRO services for clinical trials including feasibility, regulatory and ethics submissions, monitoring, site management and contract management for devices, IVDs, combination products, small molecules, biologics and ATMPs.

Multicenter preclinical proof-of-concept study coordination

Coordination services for multicenter preclinical proof-of-concept studies to harmonize protocols and data across centers.

Expertise Areas

  • Preclinical translational research
  • Cardiovascular disease modelling
  • Metabolic disease modelling
  • Large animal (porcine, minipig) models
  • Show More (7)

Key Technologies

  • AI-assisted image analysis
  • Bioinformatics target-prediction
  • Chromatography-based exosome isolation
  • High-throughput tissue slicing and image analysis
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.